Clinical trials

Filters
Clear filters
1,718 trials
TrialSponsorPhaseStatusPrimary completion
A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe HypertriglyceridemiaNCT05610280IONSPhase 3Completed2024-08-08Actual
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial CarcinomaNCT05611931KPTIPhase 3Active not recruiting2026-05-22Actual
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset SeizuresNCT05614063XENEPhase 3Completed2026-01-12Actual
Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa InfectionNCT05616221ARMPPhase 2Completed2024-07-17Actual
A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19NCT05616728ENTAPhase 2Completed2023-02-08Actual
A Prospective Clinical Trial to Evaluate the Efficacy and Safety of Neurotropic B-Vitamins in Clinically Diagnosed Peripheral Sensory Polyneuropathy of Different Etiologies.NCT05619328Procter and GamblePhase 3Completed2023-11-02Actual
A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)NCT05619692SUPNPhase 2Completed2024-06-05Actual
Extension Study Evaluating The Safety And Tolerability of AMX0035NCT05619783AMLXPhase 3Completed2024-10-16Actual
Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809)NCT05621252PLRXPhase 2Completed2023-12-27Actual
Efficacy, Safety, and Tolerability of COMP360 in Participants With TRDNCT05624268COMPASS PathwaysPhase 3Completed2025-05-28Actual
A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy VolunteersNCT05626803VaxartPhase 2Completed2023-10-16Actual
Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of ApitegromabNCT05626855Scholar Rock, Inc.Phase 3Active not recruiting2026-11-01Estimated
A Multi-Centre, Randomised, Controlled, Masked Phase 2 Study of the Safety and Efficacy of KIO-101 Ophthalmic Solution, Versus Vehicle Control in the Treatment of Dry Eye Disease in Patients With Autoimmune DiseaseNCT05629364KPRXPhase 2Terminated2024-01-09Actual
Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA StudyNCT05629390LianBio LLCPhase 3Completed2023-09-15Actual
SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19NCT05629962AVIRPhase 3Completed2024-04-25Actual
A Study of Botensilimab in Participants With Metastatic Pancreatic CancerNCT05630183AGENPhase 2Completed2026-01-05Actual
Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic ArthritisNCT05640245MoonLake Immunotherapeutics AGPhase 2Completed2023-09-05Actual
A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's DiseaseNCT05642442Jazz PharmaceuticalsPhase 2Completed2024-10-23Actual
Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 YearsNCT05643534ArdelyxPhase 3Completed2026-08-20Actual
An Open-Label Study Evaluating Brexanolone in Adults With TinnitusNCT05645432SUPNPhase 2Completed2023-11-21Actual
Safety and Efficacy of FSD201 for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD)NCT05652907Quantum BiopharmaPhase 2Terminated2023-05-24Actual
A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's DiseaseNCT05655520SUPNPhase 3Terminated2025-01-20Actual
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)NCT05658510BioXcel Therapeutics IncPhase 3Completed2025-08-15Actual
Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED LampNCT05662202BFRIPhase 3Completed2025-09-03Actual
A Phase 3 Study of Obexelimab in Patients With IgG4-Related DiseaseNCT05662241Zenas BioPharma (USA), LLCPhase 3Active not recruiting2025-11-13Actual
NKTR-255 vs Placebo Following CD19-directed CAR-T Therapy in Patients With Relapsed/Refractory Large B-cell LymphomaNCT05664217NKTRPhase 2, Phase 3Terminated2024-05-22Actual
Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III)NCT05665088BioXcel Therapeutics IncPhase 3Terminated2023-09-11Actual
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic SeizuresNCT05667142XENEPhase 3Recruiting2027-04Estimated
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)NCT05667493IONSPhase 3Enrolling by invitation2029-08Estimated
Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPANCT05667662PULMPhase 2Terminated2024-02-27Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.